Phase I Study of PM54 Administered to Patients with Advanced Solid Tumors
PM54-A-002-24
Phase 1 other active
Quick answer
Phase I Study of PM54 Administered to Patients with Advanced Solid Tumors for Selected Advanced Solid Tumors is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Selected Advanced Solid Tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active